NM_001042475.3:c.1020+16962C>T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001042475.3(CEP85L):​c.1020+16962C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.464 in 151,784 control chromosomes in the GnomAD database, including 16,872 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.46 ( 16872 hom., cov: 32)

Consequence

CEP85L
NM_001042475.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0210

Publications

6 publications found
Variant links:
Genes affected
CEP85L (HGNC:21638): (centrosomal protein 85 like) The protein encoded by this gene was identified as a breast cancer antigen. Nothing more is known of its function at this time. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2010]
PLN (HGNC:9080): (phospholamban) The protein encoded by this gene is found as a pentamer and is a major substrate for the cAMP-dependent protein kinase in cardiac muscle. The encoded protein is an inhibitor of cardiac muscle sarcoplasmic reticulum Ca(2+)-ATPase in the unphosphorylated state, but inhibition is relieved upon phosphorylation of the protein. The subsequent activation of the Ca(2+) pump leads to enhanced muscle relaxation rates, thereby contributing to the inotropic response elicited in heart by beta-agonists. The encoded protein is a key regulator of cardiac diastolic function. Mutations in this gene are a cause of inherited human dilated cardiomyopathy with refractory congestive heart failure, and also familial hypertrophic cardiomyopathy. [provided by RefSeq, Apr 2016]
PLN Gene-Disease associations (from GenCC):
  • dilated cardiomyopathy 1P
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • intrinsic cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hypertrophic cardiomyopathy 18
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.535 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP85LNM_001042475.3 linkc.1020+16962C>T intron_variant Intron 3 of 12 ENST00000368491.8 NP_001035940.1 Q5SZL2-1Q3ZCQ5
PLNNM_002667.5 linkc.-98+175G>A intron_variant Intron 1 of 1 ENST00000357525.6 NP_002658.1 P26678Q5R352

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP85LENST00000368491.8 linkc.1020+16962C>T intron_variant Intron 3 of 12 1 NM_001042475.3 ENSP00000357477.3 Q5SZL2-1
PLNENST00000357525.6 linkc.-98+175G>A intron_variant Intron 1 of 1 1 NM_002667.5 ENSP00000350132.5 P26678

Frequencies

GnomAD3 genomes
AF:
0.465
AC:
70475
AN:
151666
Hom.:
16874
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.393
Gnomad AMI
AF:
0.409
Gnomad AMR
AF:
0.344
Gnomad ASJ
AF:
0.446
Gnomad EAS
AF:
0.303
Gnomad SAS
AF:
0.485
Gnomad FIN
AF:
0.523
Gnomad MID
AF:
0.567
Gnomad NFE
AF:
0.540
Gnomad OTH
AF:
0.435
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.464
AC:
70493
AN:
151784
Hom.:
16872
Cov.:
32
AF XY:
0.460
AC XY:
34113
AN XY:
74180
show subpopulations
African (AFR)
AF:
0.392
AC:
16238
AN:
41402
American (AMR)
AF:
0.343
AC:
5231
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.446
AC:
1548
AN:
3468
East Asian (EAS)
AF:
0.303
AC:
1563
AN:
5152
South Asian (SAS)
AF:
0.485
AC:
2339
AN:
4820
European-Finnish (FIN)
AF:
0.523
AC:
5502
AN:
10522
Middle Eastern (MID)
AF:
0.572
AC:
167
AN:
292
European-Non Finnish (NFE)
AF:
0.540
AC:
36614
AN:
67858
Other (OTH)
AF:
0.435
AC:
918
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1935
3870
5805
7740
9675
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
652
1304
1956
2608
3260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.463
Hom.:
4324
Bravo
AF:
0.445
Asia WGS
AF:
0.373
AC:
1297
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
8.6
DANN
Benign
0.68
PhyloP100
-0.021
PromoterAI
0.083
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3752581; hg19: chr6-118869730; API